Avastin

Keytruda: Merck’s cancer drug shines and falters at ESMO

Keytruda: Merck’s breakthrough cancer drug with mixed results at ESMO

Anika Sharma

Merck & Co. made significant strides at this year’s European Society for Medical Oncology (ESMO) congress, presenting a series of ...

Roche denounces counterfeit Avastin that caused blindness in Pakistan

Roche denounces counterfeit Avastin that caused blindness in Pakistan

Anika Sharma

Following a distressing incident in which several diabetic patients were administered a counterfeit version of Roche’s Avastin, resulting in the ...

Lytenava, Outlook Therapeutics, Avastin, Roche, wet AMD, bevacizumab-vikg, Complete response letter

Outlook’s eye drug Lytenava fails to win FDA approval, despite positive trial

Anika Sharma

Outlook Therapeutics has been working on a reformulated version of Roche’s cancer drug Avastin for the treatment of certain eye ...